ArticleBiochimica et biophysica acta. Molecular cell research2026

Corrigendum to "Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor role" [BBA Mol. Cell Res. 1873 (2026) 120081].

Evodie Koutouan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.